Literature DB >> 7930585

Functional analysis of the serpin domain of C1 inhibitor.

M Coutinho1, K S Aulak, A E Davis.   

Abstract

To analyze the role of the heavily glycosylated amino-terminal domain of C1 inhibitor in protease inhibitory activity, two truncated C1 inhibitor molecules were constructed. The abilities of the recombinant truncated inhibitors to complex with target proteases were compared with that of the wild-type recombinant protein. One recombinant truncated molecule consisted of amino acid residues 76 to 478 (C-serp(76)) and the other of residues 98 to 478 (C-serp(98)). The recombinant proteins were each expressed in similar quantities. The thermal denaturation profiles of the two truncated proteins were similar to that of the wild-type protein. Identical binding of C1s, C1r, kallikrein, and beta factor XIIa was observed with the three molecules. Furthermore, the truncated molecules also effectively inhibited C1 activity in hemolytic assays. These studies therefore clearly demonstrate that the amino-terminal domain of C1 inhibitor does not influence complex formation with target proteases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930585

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  alpha(1)-Proteinase inhibitor mutants with specificity for plasma kallikrein and C1s but not C1.

Authors:  Thomas Sulikowski; Bryan A Bauer; Philip A Patston
Journal:  Protein Sci       Date:  2002-09       Impact factor: 6.725

2.  Production of multidomain complement glycoproteins in insect cells.

Authors:  P Závodzky; S Cseh
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

3.  Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema.

Authors:  E Verpy; M Biasotto; M Brai; G Misiano; T Meo; M Tosi
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

4.  N-linked glycosylation at Asn3 and the positively charged residues within the amino-terminal domain of the c1 inhibitor are required for interaction of the C1 Inhibitor with Salmonella enterica serovar typhimurium lipopolysaccharide and lipid A.

Authors:  Dongxu Liu; Cort C Cramer; Jennifer Scafidi; Alvin E Davis
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  The StcE protease contributes to intimate adherence of enterohemorrhagic Escherichia coli O157:H7 to host cells.

Authors:  Thomas E Grys; Matthew B Siegel; Wyndham W Lathem; Rodney A Welch
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

Review 6.  C1 inhibitor: molecular and clinical aspects.

Authors:  Marco Cicardi; Lorenza Zingale; Andrea Zanichelli; Emanuela Pappalardo; Benedetta Cicardi
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

7.  Complete sequencing and expression of three complement components, C1r, C4 and C1 inhibitor, of the classical activation pathway of the complement system in rainbow trout Oncorhynchus mykiss.

Authors:  Tiehui Wang; Christopher J Secombes
Journal:  Immunogenetics       Date:  2003-11-20       Impact factor: 2.846

8.  N-linked glycosylation is required for c1 inhibitor-mediated protection from endotoxin shock in mice.

Authors:  Dongxu Liu; Xiaogang Gu; Jennifer Scafidi; Alvin E Davis
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

9.  Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7.

Authors:  Wyndham W Lathem; Tessa Bergsbaken; Rodney A Welch
Journal:  J Exp Med       Date:  2004-04-19       Impact factor: 14.307

10.  N- and O-glycosylation Analysis of Human C1-inhibitor Reveals Extensive Mucin-type O-Glycosylation.

Authors:  Kathrin Stavenhagen; H Mehmet Kayili; Stephanie Holst; Carolien A M Koeleman; Ruchira Engel; Diana Wouters; Sacha Zeerleder; Bekir Salih; Manfred Wuhrer
Journal:  Mol Cell Proteomics       Date:  2017-12-12       Impact factor: 5.911

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.